VILOR reaffirmed 2026 guidance for approximately $10.4 billion in net sales and $2.8 billion operating EBITDA, expecting about 27% margin; licensing gains supported growth, while Q3 sales declined 1% amid weather and Brazil’s licensing transition.
VYLR · Vylor Inc.
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Price & Indicators
Key stats
- Close
- $67.77
- Open
- $70.04
- Day range
- $67.70–70.55
- Available closing range
- $67.26–76.94
- Average volume, 30 days
- 3.8M
- Short interest
- 13.9M · 2.1% of shares · 4.1 days
- Short volume, last session
- 34%
- Last earnings
- Nov 12, 2026
- Latest filing
- 10-Q · Nov 12
- Price history
- Oct 2026 to Nov 2026
The closing range uses available history since Oct 1, 2026; less than a full year is stored.
Up next
Latest documents
Vylor Inc. registered a shelf for future sales of common stock, preferred stock, depositary shares, debt securities, warrants, subscription rights, purchase contracts and purchase units. Proceeds are expected to fund general corporate purposes unless otherwise stated.
Vylor Inc. became an independent publicly traded company on October 1, 2026 after Corteva’s seed operating segment was separated, creating two independent publicly traded companies.
Vylor Inc. reaffirmed full-year 2026 guidance, expecting Adjusted Pro Forma Operating EBITDA of approximately $2.8 billion and Adjusted Pro Forma Operating EPS of $2.25 to $2.35 per share. Third-quarter GAAP pro forma loss from continuing operations after income taxes was $480 million.
Vylor Inc. completed its separation from Corteva, Inc. on October 1, 2026. Nine-month pro forma sales were 8,531 million, net income attributable to Vylor was 1,005 million, and total assets were 23,194 million as of September 30, 2026.
Metrics snapshot
Useful current figures from the complete screener profile.
Quarterly results
Equibles Rating
blended score · not investment adviceBlended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders SellIllustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from written earnings releases and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Adjusted Pro Forma Operating EBITDA non-GAAP | $2.66B | Nine Months Ended September 30, 2026 | — |
| Adjusted Pro Forma Operating EPS (Non-GAAP) non-GAAP | $2.37 | Nine Months Ended September 30, 2026 | — |
| Adjusted pro forma segment operating EBITDA non-GAAP | $92M | third quarter of 2026 | — |
| Approximate Value of Shares that May Yet Be Purchased Under the Program | $1.93B | the three months ended September 30, 2026 filing | — |
| Base income tax rate from continuing operations (Non-GAAP) non-GAAP | 24.4% | Nine Months Ended September 30, 2026 | — |
| Base income tax rate from continuing operations, post-management adjustment (Non-GAAP) non-GAAP | 24.4% | Nine Months Ended September 30, 2026 | — |
| Exchange gains (losses), net effect non-GAAP | -0.3% | Nine Months Ended September 30, 2026 | — |
| Operating Earnings (Loss) (Non-GAAP) non-GAAP | -$276M | the three months ended September 30, 2026 filing | — |
GAAP → non-GAAP reconciliationGAAP Income (loss) from continuing operations attributable to Corteva common stockholders (GAAP) -529M
+0M Non-operating benefits (costs), after tax
+105M Amortization of intangibles (existing as of Corteva Separation), after tax
-4M Mark-to-market gains (losses) on certain foreign currency contracts not designated as hedges, after tax
+66M Significant items benefit (charge), after tax
+86M Separation costs, after tax
= Operating Earnings (Loss) (Non-GAAP) -276M
|
|||
| Operating Earnings (Loss) Per Share (Non-GAAP) non-GAAP | -$0.41 | the three months ended September 30, 2026 filing | — |
GAAP → non-GAAP reconciliationGAAP Earnings (loss) per share of common stock from continuing operations attributable to Corteva com -$0.79
+$0 Non-operating benefits (costs), after tax
+$0.16 Amortization of intangibles (existing as of Corteva Separation), after tax
-$0.01 Mark-to-market gains (losses) on certain foreign currency contracts not designated as hedges, after tax
+$0.1 Significant items benefit (charge), after tax
+$0.13 Separation costs, after tax
= Operating Earnings (Loss) Per Share (Non-GAAP) -$0.41
|
|||
| Operating EBITDA non-GAAP | -$68M | the three months ended September 30, 2026 filing | — |
| Pro Forma Operating EBITDA non-GAAP | $2.61B | Nine Months Ended September 30, 2026 | — |
| Pro Forma Organic Change non-GAAP | -30% | Q3 2026 vs. Q3 2025 | — |
| Pro Forma Organic Sales non-GAAP | $8.41B | Nine Months Ended September 30, 2026 | — |
| Rest of World Adj. Pro Forma Segment Op. EBITDA non-GAAP | $92M | third quarter of 2026 | — |
| Segment operating EBITDA (Crop Protection) | 213M | the three months ended September 30, 2026 filing | — |
| Segment operating EBITDA (Seed) | -246M | the three months ended September 30, 2026 filing | — |
| Segment operating EBITDA (Total) | -33M | the three months ended September 30, 2026 filing | — |
| Trade receivables sold under these agreements | $14M | the three months ended September 30, 2026 filing | — |
| YTD Rest of World Adj. Pro Forma Segment Op. EBITDA non-GAAP | $555M | first nine months of 2026 | — |
Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period
Versus peers
Shell Companies — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
VYLR
this stock
Vylor Inc.
|
$45.22B | — | — | — | 2.1% |
|
CLUS
Cluster Group Holdings Ltd Co
|
$8.00B | — | — | — | — |
|
DMII
Drugs Made In America Acquisition II Corp.
|
$652.92M | +3.5% | — | — | 0.2% |
|
BCSS
Bain Capital GSS Investment Corp.
|
$607.94M | +3.3% | — | — | 0.0% |
|
EVAC
EQV Ventures Acquisition Corp. II
|
$606.69M | +3.5% | — | — | 0.0% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every section- % held
- 0.0%
- Net QoQ
- +14.2K sh
- Top holder
- STALEY CAPITAL ADVISERS I…
- Filed
- Nov 12, 2026
- This year
- 15
Vylor Inc. registered a shelf for future sales of common stock, preferred stock, depositary shares, debt securities, warrants, subscription rights, purchase contracts and purchase units. Proceeds are expected to fund general corporate purposes unless otherwise stated.
ViewPerformance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| VYLR | -6.0% | -4.7% | — | -6.4% | — |
| SPY | -5.5% | -6.3% | -5.6% | -5.3% | +5.0% |
| vs SPY | -0.5% | +1.6% | — | -1.1% | — |
Capital returns
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.